Related Experiment Video
Updated: May 14, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
Cyclin D1-negative mantle cell lymphoma
1Aichi Cancer Center Research Institute, Japan.
Insights
Mantle cell lymphoma (MCL) lacking Cyclin D1 (CCND1) often shows CCND2 gene rearrangement, particularly with immunoglobulin light chain genes, according to Salaverria et al.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Mantle cell lymphoma (MCL) is a B-cell non-Hodgkin lymphoma.
- Cyclin D1 (CCND1) expression is a hallmark of classical MCL.
- Alternative genetic mechanisms are implicated in CCND1-negative MCL variants.
Purpose of the Study:
- To investigate the genetic landscape of CCND1-negative, SOX11-positive MCL.
- To identify alternative genetic drivers in this MCL subtype.
Main Methods:
- Analysis of gene rearrangements in MCL patient samples.
- Focus on CCND1-negative and SOX11-positive cases.
- Detection of CCND2 rearrangements and their association with immunoglobulin genes.
Main Results:
- Over half of CCND1-negative, SOX11-positive MCL cases exhibited CCND2 gene rearrangement.
- CCND2 rearrangement was predominantly observed in conjunction with immunoglobulin (IG) light chain genes.
- This suggests an alternative pathway for MCL pathogenesis in a subset of patients.
Conclusions:
- CCND2 gene rearrangement is a frequent finding in CCND1-negative, SOX11-positive MCL.
- This rearrangement may play a significant role in the pathogenesis of these MCL cases.
- Findings highlight the genetic heterogeneity within MCL and potential therapeutic targets.
Abstract:
In this issue of Blood, Salaverria et al report that more than half of Cyclin D1- (CCND1) negative SOX11-positive mantle cell lymphoma (MCL) had CCND2 gene rearrangement predominantly with immunoglobulin (IG) light chain genes.(1)
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity
Abnormal Proliferation
Anaphase Promoting Complex
